AEIRO
All articles
TechnologyFebruary 24, 20258 min read

How Targeted Bipolar Pulsed Ionization (TBPI®) works.

An introduction to TBPI’s intended mechanism and controls, the limits of ionization research, and the model-specific evidence needed to evaluate performance.

Illustration of charged particles used to introduce ionization

Targeted Bipolar Pulsed Ionization (TBPI®) is AEIRO’s name for an ionization approach intended for use with an HVAC system. This article explains the proposed mechanism and manufacturer-described controls. Those descriptions do not, by themselves, establish particle-removal rates, pathogen reduction, disease prevention, energy savings, or emissions performance for an AEIRO model.

What is Targeted Bipolar Pulsed Ionization (TBPI®)?

Bipolar ionization uses electrical energy to generate positively and negatively charged ions. Ionizers can charge airborne particles, affecting how those particles interact with other particles and surfaces. Charging a particle is not the same as removing it from the occupied space.

AEIRO describes TBPI as a controllable, pulsed approach to ion generation. The intended role of the controls is to vary the ion output for a selected application. Whether a particular setting produces a useful result must be established for the model, operating conditions, and contaminant being evaluated.

Design and controls.

In AEIRO’s description, a user-selected mode can adjust the balance of positive and negative ions, the timing between pulses, and the electrode voltage. These are descriptions of the intended control strategy. A mode name or adjustable setting does not demonstrate that a device removes a named contaminant or outperforms another air-cleaning method. Confirm available controls and operating limits in the documentation for the exact model.

How does it work?

  • Ion generation: An energized emitter produces ions in the air near the device.
  • Airflow and exposure: Installation location, airflow, and operating conditions determine where treatment occurs. Ion generation at the device does not establish the ion concentration throughout a room.
  • Particle interactions: Charged particles may attach to other particles or deposit on surfaces. Material deposited on room surfaces may later become airborne again.
  • Collection and measurement: Any claimed improvement in filter capture needs a comparison with the same filter and airflow under comparable conditions. Particle charging alone is not evidence of improved filtration.
  • Microbial testing: A reduction in recoverable organisms in a particular test must be assessed within that test’s methods and conditions. It does not establish a general pathogen-deactivation rate or a reduction in illness.

Evaluating intended benefits.

Ask for evidence that identifies the tested model and configuration, device settings, airflow, filter, target particle or organism, exposure duration, room or chamber conditions, and the untreated comparison. Review the measured outcome and its uncertainty, rather than treating results for another device as product-wide evidence.

For example, the PLOS ONE study by Sobek and Elias tested a GPS-FC48-AC device in a controlled, sealed biosafety-level-3 chamber. It measured infective airborne viruses during laboratory trials; it was not a clinical trial of disease transmission. The paper reports GPS Air funding and author relationships with the company. Its results should not be transferred automatically to an AEIRO TBPI model or an occupied building.

  • Particles and filtration: Request size-specific removal measurements and a filter-only comparison before claiming an added filtration benefit.
  • Viruses, bacteria, and mold: Match any claim to the tested organism, method, duration, and device. Do not infer prevention of infection from a chamber result.
  • VOCs and odors: Identify the individual compounds and measured concentrations. A particle-removal result does not demonstrate gas or odor removal.
  • Ventilation and energy: This article establishes no reduction in outdoor-air requirements or energy use. Any proposed change needs a project-specific engineering assessment.
  • Dust and static: Treat these as separate applications requiring suitable measurements, rather than assumed benefits of an ionization setting.

Potential drawbacks and limitations.

EPA describes bipolar ionization as an emerging technology with less documented field performance and safety than established filtration approaches. EPA also notes the potential for ozone and other by-products. General descriptions of ionization cannot establish the emissions profile of a particular installation.

  • Model-specific emissions evidence: Review current test reports and the scope of any listing or validation for the exact device and configuration. A general claim that a technology is safe or ozone-free is insufficient.
  • Installation and operation: Check the manufacturer’s instructions, compatible HVAC conditions, service requirements, and any limits attached to the test evidence.
  • Air-quality planning: Air cleaning supplements source control and ventilation. Selecting an ionizer does not, on its own, establish that ventilation can be reduced.
  • Site verification: Define the intended outcome and measurement method before installation, and assess performance under the actual operating conditions.

UL 867 and UL 2998 describe different claims.

UL 867 is the standard for Electrostatic Air Cleaners. A model’s listing to that standard is a separate claim from validation of ozone emissions. It does not, by itself, establish UL 2998 validation.

UL 2998 (also styled ULE 2998) is an environmental claim validation procedure for ozone emissions from air cleaners. UL Solutions describes its Zero Ozone Emissions validation as ozone below a 0.005 ppm (5 ppb) quantification limit under the test conditions. That threshold should not be read as literally zero ozone, proof of pathogen removal, or proof that every other by-product is absent.

For a particular product, match any listing or validation statement to the manufacturer, exact model and configuration, issuing organization, record identifier, current status, and covered conditions. A data-sheet statement of compliance alone should not be presented as independent listing or validation. This article makes no UL listing or validation claim for an AEIRO model.

Sources.

  1. U.S. EPA. Air Cleaners, HVAC Filters, and Respiratory Viruses. Guidance on air-cleaning roles, evidence limitations, and potential by-products. https://www.epa.gov/indoor-air-quality-iaq/air-cleaners-hvac-filters-and-respiratory-viruses
  2. U.S. EPA. What are ionizers and other ozone generating air cleaners? Background on particle charging, deposition, and emissions. https://www.epa.gov/indoor-air-quality-iaq/what-are-ionizers-and-other-ozone-generating-air-cleaners
  3. Sobek, E., and Elias, D. A. (2023). Bipolar ionization rapidly inactivates real-world, airborne concentrations of infective respiratory viruses. PLOS ONE 18(11), e0293504. Controlled-chamber study of a GPS-FC48-AC; not AEIRO model validation. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0293504
  4. UL Standards & Engagement. UL 867: Electrostatic Air Cleaners. Standard scope. https://www.shopulstandards.com/ProductDetail.aspx?productId=UL867_5_S_20110804
  5. UL Solutions. Zero Ozone Emissions Validation. ULE 2998 scope, ozone quantification limit, and product validation program. https://www.ul.com/services/zero-ozone-emissions-validation
Published February 24, 2025 · 8 min read
Keep reading

Related articles.